Epstein-Barr virus mediated graft rejection in heart transplant patients: implication of the cardiac cytoskeleton.
LeBlanc
M H
MH
Quebec Heart Institute, Ste-Foy, Canada.
Boudriau
S
S
Doyle
D
D
Gagnon
A
A
Beaudoin
D
D
Coulombe
D
D
Gleeton
O
O
Kingma
J G
JG
Boutet
M
M
D002467:Cell Nucleus / Q000473:pathology / Q000648:ultrastructure; D003599:Cytoskeleton / Q000473:pathology* / Q000648:ultrastructure; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology* / Q000821:virology; D006321:Heart / Q000821:virology; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology*; D006566:Herpesviridae Infections / Q000150:complications*; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D006801:Humans; D008223:Lymphoma / Q000209:etiology / Q000276:immunology / Q000473:pathology; D008232:Lymphoproliferative Disorders / Q000209:etiology / Q000276:immunology / Q000473:pathology; D008854:Microscopy, Electron; D009206:Myocardium / Q000648:ultrastructure; D017464:Receptors, Complement 3d / Q000032:analysis; D017455:Receptors, IgE / Q000032:analysis; D011991:Receptors, Virus / Q000032:analysis; D014412:Tumor Virus Infections / Q000150:complications*; D014617:Vacuoles / Q000473:pathology / Q000648:ultrastructure
D017464:Receptors, Complement 3d; D017455:Receptors, IgE; D011991:Receptors, Virus